RxDoctor Payments Data

Patrick Greenburg

Family Medicine · Bentonville, ARNPI 1336569532

Payments from drug & device makers

$8,314in general payments, 2019–2025

Across 544 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AbbVie$1K
  • Pfizer$838
  • AstraZeneca$733
  • Novo Nordisk$638
  • Amgen$502
  • plus $3K from 32 others

What the payments were for

  • Food & beverage$8,308100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,314 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$57,338
Medicare patients
139
Services billed
890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$92,949
EliquisApixaban77$69,944
JardianceEmpagliflozin50$65,338
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$37,120
XareltoRivaroxaban23$31,086
MounjaroTirzepatide27$30,988
TrulicityDulaglutide13$19,301
Breo ElliptaFluticasone/Vilanterol21$13,211
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$13,010
FarxigaDapagliflozin Propanediol14$11,344
Emgality PenGalcanezumab-Gnlm13$8,842
BelsomraSuvorexant18$7,600
Gabapentin157$4,546
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$3,315
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$3,063

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$638$95,29968 claims
PfizerEliquis$838$69,94477 claims
Boehringer IngelheimJardiance$480$65,33850 claims
GSKTrelegy Ellipta, Breo Ellipta$1,063$50,33257 claims
Lilly USA, LLCMounjaro, Trulicity$401$50,28940 claims
Johnson & JohnsonXarelto$52$31,08623 claims
AstraZenecaBreztri Aerosphere, Farxiga$733$24,35336 claims
MerckBelsomra$421$7,60018 claims
Sanofi-aventis U.S. LLCLantus$86$2,14111 claims
AbbVieSynthroid$1,053$95723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Bentonville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →